Tiamina

Quick links to important sections

Tiamina

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tiamina

Property Description
Active ingredient Thiamine Hydrochloride (Vitamin B1)
Forms Tablet, Capsule, Injectable Solution
Pharmacological class B Vitamin, Essential Nutrient Supplement
Common purpose Maintaining metabolic balance, preventing deficiency
Origin Synthetic

Tiamina is a medicinal preparation whose active substance is Thiamine Hydrochloride, chemically synonymous with Vitamin B1, and is classified primarily as a B Vitamin and an essential nutrient supplement. This compound, although identical in function to the vitamin found in food, is typically produced through synthetic processes for pharmaceutical use. As a high-level pharmacological class, Tiamina belongs to the group of water-soluble vitamins, meaning it is not stored in large reserves in the body, which highlights the need for consistent intake to prevent depletion. The role of thiamine in human health is clinically recognized by major medical bodies for its necessity in metabolic function.


Thiamine Composition and Available Forms

The composition of Tiamina is based on the active ingredient Thiamine Hydrochloride (INN), a chemically stable salt form of Vitamin B1 often prepared with solid excipients for oral use or an aqueous solution for injection. This form is often chosen over Thiamine Mononitrate due to its higher solubility, making it suitable for a wider range of preparations. Tiamina is widely available in several high-level dosage forms, most commonly as an oral tablet or capsule, often marketed for adult patients seeking general nutritional support.


What is the General Purpose of Taking Vitamin B1?

The general purpose of taking Tiamina is to ensure the body's fundamental metabolic processes are supported by maintaining adequate levels of this essential nutrient. Thiamine acts as a crucial cofactor that is converted into Thiamine Pyrophosphate (TPP), which is indispensable for facilitating the conversion of carbohydrates into cellular energy (ATP). By supporting this core function, Tiamina aids in the proper operation of the nervous and cardiovascular systems. This confirms that the supplement's overall benefit is to support vital metabolic balance and prevent conditions associated with nutritional deficiency, which is its primary application.

Regulatory References

  1. Thiamine - eEML

What side effects are possible with Tiamina?

Possible side effects and safety information

The safety profile for Tiamina (Thiamine Hydrochloride) is generally characterized by rare or unknown frequency adverse reactions, with the main safety concerns revolving around hypersensitivity events. These reactions are classified by regulatory authorities across several body systems, establishing the official risk profile.


Official Adverse Reactions and Systemic Classification

The most frequently documented effects relate to hypersensitivity and administration. System-organ classes involved include Immune System Disorders and Skin and Subcutaneous Tissue Disorders, which may manifest as rash, urticaria (hives), or pruritus (itching). Gastrointestinal Disorders, such as nausea or vomiting, are also listed.

Serious Adverse Reactions and Risk Context

Official labels explicitly identify severe systemic reactions. The most serious documented adverse reactions are Anaphylactic Shock and Circulatory Collapse. These rare, life-threatening events are noted to occur particularly when the medicine is administered via the parenteral (injection) route and may appear rapidly following administration.


Population Safety and Limitations

The primary safety constraint is the contraindication for individuals with a known hypersensitivity to the active substance, Thiamine. For special populations, high doses used during pregnancy or lactation may require particular consideration. Additionally, parenteral formulations containing aluminum pose a risk of accumulation and toxicity during prolonged administration in patients with impaired kidney function, as defined in regulatory texts.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Thiamine Hydrochloride (Tiamina) focuses primarily on severe reactions documented following parenteral administration (injection), as oral overdose is considered uncommon due to the rapid excretion of excess amounts.

Documented Overdose Manifestations

Official labeling describes manifestations that range from symptoms such as nervousness, restlessness, pruritus (itching), weakness, nausea, and tightness in the throat. More serious and life-threatening outcomes are documented and include hypotension (low blood pressure), respiratory distress, vascular collapse, and anaphylactic shock.

Required Emergency Actions

In the event of a suspected overdose or the onset of severe manifestations, official regulatory guidance mandates that patients seek immediate medical attention. This instruction is critical due to the potential for rapid progression to life-threatening conditions like anaphylactic shock. No specific antidote is known for Thiamine overdose, and regulatory documents state that management must consist of symptomatic and supportive treatment. Hospital monitoring may be required to address and manage severe systemic effects like hypotension and vascular instability.

Therapeutic Uses of Tiamina

What Tiamina Treats: Main Uses and Benefits

Tiamina (Thiamine Hydrochloride) is commonly used to help manage the severe health issues that arise from a deep nutritional deficit of Vitamin B1, such as the major deficiency syndromes. Its primary role is in clinical settings that involve acute or disruptive symptom patterns linked to deficiency.

Supporting Acute Neurological and Cardiovascular Symptoms

The medication helps address conditions characterized by periods of heightened symptoms like Wernicke's encephalopathy (confusion, ataxia) and wet Beri-beri (rapid heart rate, swelling). Tiamina contributes to the therapeutic benefit that may assist with maintaining functional stability related to neurological symptoms and is relevant for easing symptoms linked to organ-specific functional stress, such as the heart.

Addressing Chronic Nerve and Systemic Imbalance

It is applied in addressing the symptom clusters associated with nutritional polyneuritis (pain, numbness, weakness). The treatment supports the patient during difficult episodes by easing overall sensory distress and may assist with maintaining functional stability related to nerve function for patients with prolonged thiamine inadequacy.


Quick Fact: Relief for Deficiency Syndromes
Tiamina is relevant in contexts involving heightened systemic burden, specifically addressing conditions marked by increased physiological stress due to severe Vitamin B1 deficiency. It contributes to easing the systemic imbalance and supports patients during episodes of heightened discomfort.

Regulatory References

  1. NIH MedlinePlus Drug Information on Thiamine

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Tiamina — Official Regulatory Information

The eligibility profile for Tiamina (Thiamine Hydrochloride) is defined by its officially documented population restrictions, primarily focusing on allergies and age limitations for specific product forms, as stated by government regulatory bodies.


Populations Prohibited or Restricted from Use

Classification Population/Condition Regulatory Statement (Official Basis)
Absolute Contraindication Patients with known hypersensitivity (allergy) to thiamine or any component of the formulation. Prohibited from use.
Conditional Prohibition Patients with severe hereditary problems like glucose-galactose malabsorption. Prohibited only from specific oral tablet forms containing relevant excipients (e.g., lactose).
Use Not Recommended Children under three years of age. Not recommended for specific oral tablet formulations (per some EU labels).

Conditional Use and Established Eligibility

  • Age Groups: Use is established in adults and in pediatric patients for treating acute thiamine deficiency syndromes (e.g., infantile beriberi). However, for certain combination products, safety and effectiveness in children below 11 years have not been established.
  • Pregnancy and Lactation: The injectable form is classified as FDA Pregnancy Category A at therapeutic doses, indicating a low risk. Caution is advised during lactation, as it is not universally known if the drug is excreted in human milk.
  • Renal Function: Caution is required for patients with impaired kidney function receiving parenteral (injectable) forms, due to the potential for excipient accumulation (e.g., aluminum).

What should I know about interactions with other medicines?

Interactions with other medicines and products

Tiamina (Thiamine Hydrochloride), as an essential water-soluble nutrient, has an official interaction profile focused on factors that reduce its bioavailability, cause chemical instability, or require administration timing separation.

Documented Exposure-Modifying Interactions

Substances that may decrease the body’s available thiamine levels are noted in regulatory information. The oral potassium binder Patiromer requires administration separation of at least 3 hours to minimize the risk of reduced Tiamina absorption. High-dose loop diuretics, such as Furosemide, can increase the renal clearance of thiamine, contributing to decreased levels. Furthermore, chronic or heavy alcohol use is officially documented to impair both the gastrointestinal absorption and utilization of Tiamina, severely reducing thiamine status.

Administration and Efficacy Restrictions

Specific interactions relate to the timing of administration and the drug form used. Thiamine antagonists, including the antineoplastic agents 5-Fluorouracil and Thiosemicarbazone, can neutralize the biological effect of Tiamina. In patients with suspected deficiency, official guidance requires Tiamina to be administered before or concurrently with intravenous glucose/dextrose solutions to manage rapid nutrient utilization. Additionally, injectable Tiamina is physically incompatible with moderately alkaline solutions, bisulfite solutions, and certain calcium salts, and must not be mixed with them.

Mechanism of Action

Core Mechanism: Essential Cofactor Function

Tiamina (Thiamine) is converted into the active coenzyme Thiamine Pyrophosphate (TPP), which functions as an obligate cofactor for three major enzyme complexes: the Pyruvate Dehydrogenase Complex (PDHC), alpha-Ketoglutarate Dehydrogenase Complex (alpha-KGDC), and Transketolase. Its mechanism is the direct supply of this component to facilitate enzyme function and re-establish biochemical processes.


Pathway Modulation and Physiological Consequence

The mechanism is primarily executed within the mitochondria by enabling PDHC and alpha-KGDC, which are integral to the TCA Cycle . TPP is mandatory for maintaining the necessary energy flux required for aerobic cellular respiration and ATP generation in highly demanding tissues, particularly the Central Nervous System (CNS) and cardiac cells.

Its action on Transketolase also engages the Pentose Phosphate Pathway (PPP), which generates precursors for nucleic acids and specific structural lipids. This mechanism contributes to the biosynthesis of components required for the maintenance of neuronal structure, including those for myelin sheaths.

Dosage and Administration Information

Tiamina (Thiamine Hydrochloride) is administered via Oral (tablet or capsule), Intramuscular (IM), or Intravenous (IV) routes, with the selection of the route based on the severity of the patient's condition. Parenteral administration (IM or IV) is used only in acute clinical scenarios that require rapid restoration of thiamine levels, whereas oral forms are used for chronic deficiency management and long-term maintenance.


Dosage and Administration Protocol

The usage protocol follows tiered dosing regimens:

Deficiency Context Route Standard Adult Regimen
Acute Syndromes (Initial Dose) IV Typically 100 mg
Severe Beriberi (Treatment) IM or IV 10 mg to 20 mg three times daily for up to two weeks
Chronic Deficiency Oral 50 mg to 100 mg once daily or in divided doses

Contextual Use and Preparation

The schedule requires administration three times daily for acute syndromes and daily for maintenance. The injectable solution must be administered slowly. For intravenous use, the solution is often diluted (e.g., in saline) and given as a slow infusion over a period such as 30 minutes. The treatment protocol specifies a procedural structure where the short-term, acute parenteral course transitions to a long-term oral maintenance regimen once the patient has stabilized. Pediatric use guidelines specify a typical treatment dose of 10 mg to 25 mg/day IM or IV for up to two weeks. The oral dosage forms may be taken independently of food intake.

Recent Clinical Evidence

Evidence for Acute Neurological Deficiency

Research exploring Tiamina's evaluation for acute, severe neurological deficiency, such as Wernicke's Encephalopathy, is primarily documented through observational studies and detailed case reports. Due to the acute nature of the condition, comparative studies against a placebo are not generally possible. The research focuses on monitoring how acute neurological signs (like confusion and coordination issues) evolve in the observed populations, predominantly adults with chronic health conditions like alcohol use disorder. While observational evidence describes the use of thiamine as the primary management approach, research exploring short-term changes provided limited insight into the most studied administration schedule.


Evidence for Chronic Deficiency and Recovery

The research foundation for chronic systemic syndromes, including Wet Beri-beri (cardiovascular symptoms) and nutritional polyneuritis (nerve pain), is built upon historical clinical descriptions and extensive case reports. Studies examined outcomes related to physiological stress and changes in sensory/motor function. Findings indicate a rapid physiological response was observed in some studies concerning acute cardiovascular dysfunction. However, research exploring long-term symptom changes for nerve damage reported that changes in chronic peripheral neuropathy symptoms were often slow, spanning weeks to months.


Follow-up, Specific Groups, and Gaps

Follow-up durations for many acute studies were limited to the immediate phase. Studies attempting to track longer-term outcomes monitored whether chronic cognitive deficits, such as Korsakoff Syndrome, appeared in the observed populations, and research has explored whether prompt thiamine use was associated with a lower rate of these outcomes. Data for certain groups, including infants born to mothers with inadequate intake or pregnant individuals with hyperemesis gravidarum, remain insufficient. Key gaps include establishing the optimal administration schedule and fully characterizing the variability of long-term functional recovery, which remains low certainty across studies.

Key Studies & References

  1. Wernicke's Encephalopathy: Role of Thiamine (Review focusing on clinical signs, diagnosis, and treatment principles)

Frequently Asked Questions (FAQ)

Common questions about Tiamina (FAQ)


Q: Can taking Tiamina cause stomach upset or nausea?

A: Yes, official safety profiles list gastrointestinal upset, which can include symptoms like nausea or stomach pain, as a possible adverse effect. These effects are generally noted as rare or of unknown frequency in official safety profiles.

Q: Will Tiamina help with fatigue or just a vitamin deficiency?

A: Official documents describe Tiamina's primary role in helping the body break down food and release energy. Signs of a deficiency can sometimes include fatigue. Official texts frame the drug’s purpose as supporting vital metabolic balance and preventing deficiency, rather than addressing general fatigue as a primary application.

Q: Is it possible to take too much Tiamina?

A: Tiamina is a water-soluble vitamin, meaning the body does not store large reserves. Excess amounts are generally excreted from the body through the urine. Regulatory texts describe that, due to this rapid excretion, taking excessive amounts is generally not associated with harm.

Q: Can people with kidney problems use Tiamina?

A: Official regulatory texts advise caution when the injectable form of Tiamina is used for patients with impaired kidney function. This is due to the potential for excipient (inactive ingredient) accumulation, such as aluminum, with prolonged use. Safety considerations for the oral forms in patients with kidney concerns are addressed on an individual basis by a healthcare provider.

Q: Is there a link between Tiamina and heart health?

A: Yes, regulatory information from authorities in the European Union states that Tiamina contributes to the normal function of the heart. This is consistent with its known role in maintaining the necessary energy flux for high-demand tissues, including cardiac cells.

Q: Why do I see Tiamina injections sometimes, and how is that different from tablets?

A: The route of administration (injection vs. tablet) is selected based on the severity of the patient's condition. The parenteral administration (injection into a muscle or vein) is used in acute clinical scenarios when rapid restoration of thiamine levels is necessary. Oral tablets or capsules are typically used for managing chronic deficiency and long-term maintenance.

Q: How long does it take for Tiamina to start working?

A: Research has observed that the physiological response to Tiamina can vary based on the condition being treated. Studies concerning acute cardiovascular dysfunction have shown rapid responses. However, changes in chronic conditions, such as peripheral nerve damage, have been reported to be slow, spanning weeks to months.

Q: What happens if I forget to take my Tiamina dose?

A: Official patient information advises that missing one or two doses will likely not matter in the overall treatment. Official guidance suggests that if a dose is remembered soon after the scheduled time, the missed dose may be taken. If it is nearly time for the next scheduled dose, the official guidance is to skip the missed dose and proceed with the next one.

Q: Is there a blood test to check my Tiamina levels?

A: Yes, thiamine status is typically assessed using a specialized blood test. This test measures the level of Thiamine Diphosphate (TDP) in whole blood, which is considered the most reliable method for accurately determining the body's active Vitamin B1 status.

Q: Does Tiamina interact with alcohol?

A: Yes, long-term or heavy consumption of alcohol is officially documented to stop the body from properly absorbing and utilizing Tiamina. Alcohol use is documented to impair both absorption and utilization, which may severely reduce thiamine status.

Q: Is Tiamina used for anything other than deficiency?

A: Tiamina's primary purpose, according to regulatory documents, is to support vital metabolic balance and prevent conditions associated with nutritional deficiency. This is achieved through its role as an essential cofactor in cellular energy production.

Q: Are there any specific foods that interact with Tiamina absorption?

A: While specific medications and alcohol are listed as having documented interactions, official nutritional documents note that the type of food and other dietary sources consumed can generally affect the body's absorption of thiamin.

Q: How is Tiamina different from other B vitamins, like B6 or B12?

A: Tiamina (B1) is distinguished from other B vitamins by its specific function. Its primary role is to help the body break down and release energy from food and support the health of the nervous system. This differs from B6, which helps store energy from proteins, or B12, which is critical for making red blood cells.

Q: Does Tiamina have any known effect on blood sugar levels?

A: Tiamina is known to act as a coenzyme in the metabolism of glucose (sugar). Research suggests that high-dose supplementation may have a role in improving blood pressure and reducing vascular alterations in individuals with hyperglycemia (high blood sugar).

Q: What does the research say about Tiamina for cognitive function?

A: Research has focused extensively on the role of Tiamina in Wernicke-Korsakoff Syndrome, a severe cognitive condition. Studies have noted that insufficiency is linked to changes in brain glucose metabolism, and research continues to explore its potential application for certain cognitive disorders.

Q: Can Tiamina cause allergic reactions?

A: Yes, official safety information documents that Tiamina can, in rare cases, cause a very serious allergic reaction, known as anaphylaxis. This risk is noted particularly with the injectable form. Symptoms can include rash, swelling of the face or throat, and difficulty breathing.

Q: Do different forms of Tiamina (like benfotiamine) work differently?

A: Yes, different chemical forms of Vitamin B1 can work differently in the body. Benfotiamine, for example, is a synthetic, fat-soluble precursor of Vitamin B1. Research has shown that, due to its fat-solubility, it may produce higher blood levels of active thiamine than the standard water-soluble form.

Q: Why is Tiamina sometimes mentioned alongside beriberi?

A: Tiamina (Vitamin B1) is mentioned alongside beriberi because beriberi is the classical name for the disease caused by a severe, clinical lack of this essential vitamin. Tiamina is the primary management for this condition.

Q: What if I take a multivitamin that already contains Tiamina?

A: Tiamina is a common component in supplements. Official guidance advises patients to review the labels of all other supplements they are taking, as many multivitamins and mineral products already contain Tiamina.

Q: Are there any herbal supplements that interact with Tiamina?

A: Official patient information suggests that patients discuss the use of any herbal remedies or supplements with a healthcare provider before taking them alongside Tiamina.

Q: Can Tiamina be taken on an empty stomach?

A: Official nutritional references indicate that the absorption of Tiamina supplements is not shown to differ significantly when administered with food, such as breakfast, or when taken on an empty stomach.

Q: Why is Tiamina listed as a 'water-soluble' vitamin?

A: Tiamina is classified as water-soluble because of how it behaves in the body. Unlike fat-soluble vitamins, it is generally not stored in the body's tissues in large, long-term reserves. This requires more consistent intake to maintain adequate levels.

Q: Does the body store Tiamina?

A: Tiamina, as a water-soluble vitamin, is generally not stored in the body's tissues for long periods. Any excess amounts that the body does not immediately use are typically passed out of the body through the urine.

Q: What happens to the body if you have a severe Tiamina deficiency?

A: Severe deficiency is documented to result in serious clinical problems. These can include permanent nerve damage, loss of hearing, and in the most severe cases, damage to the brain or heart, and coma.

How should Tiamina be stored and disposed of?

Storing and Disposing of Tiamina (Thiamine)


Official Storage Conditions

Tiamina (Thiamine Hydrochloride) must be stored at controlled room temperature, typically defined as 20 C to 25 C (68 F to 77 F). The product must be kept out of the sight and reach of children.

Storage Requirement Rule
Temperature Do not freeze or expose to excessive heat.
Protection Keep in the original container, tightly closed, and protect from light and moisture.

Disposal Instructions

Unused or expired Tiamina must be discarded according to local regulations. Used needles and syringes from the injectable solution must be placed immediately into a designated puncture-resistant sharps container. The product should not be disposed of by throwing it into household trash or flushing it into wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tiamina found in:

A-Z Index: